Recall Z-2775-2026— KENT IMAGING, INC.

Name: FDA recall Z-2775-2026
Creator: U.S. Food and Drug Administration
Published: 2026-06-30

Class II · Ongoing

Class II FDA medical device recall by KENT IMAGING, INC., initiated 2026-06-30. It names one FDA 510(k) clearance: K242669. Product: SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.. Reason: The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected..

Recalling firm: KENT IMAGING, INC.
Classification: Class II
Status: Ongoing
Initiated: 2026-06-30
Firm location: Calgary, N/A, Canada

510(k) clearances named in this recall

1 on FDA's record

K242669 — SnapshotGLO (KB100)Kent Imaging, Inc.·cleared 2025-03-26

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

SnapshotGLO Wound Imaging Device, Model KB100, KB100AA.

Reason for recall

The software controlling the wound imaging device's battery charging circuit was not designed to recognize and recover a battery that has fully discharged into a low-power "shipping mode." When this occurs, an affected device will not resume charging when reconnected to power and becomes temporarily unusable/ unavailable for wound imaging until corrected.

Data sourced from openFDA. This site is unofficial and independent of the FDA.